Literature DB >> 7249880

Altered bile acid metabolism in primary biliary cirrhosis.

R Raedsch, B H Lauterburg, A F Hofmann.   

Abstract

Selected aspects of bile acid metabolism were assessed in six women with primary biliary cirrhosis and varying degrees of cholestasis. Urinary bile acid excretion was markedly increased and correlated highly with serum levels. In three patients in whom urinary bile acids were separated by chromatography, the majority of urinary bile acids were monosulfated (34%, 42%, 32%) or polysulfated and/or glucuronidated (30%, 20%, 38%). The monosulfates of chenodeoxycholic acid were conjugated at either the 3 position (67%, 68%, 73%) or the 7 position (33%, 32%, 27%); similarly, the monosulfates of cholic acid were conjugated at the 3 position (65%, 58%, 68%) or the 7 position (35%, 42%, 32%). The position of sulfation was not markedly influenced by the mode of amidation with glycine or taurine. Chenodeoxycholic exchangeable pool size, turnover rate, and synthesis were measured by isotope dilution and found to be well within normal limits, despite the cholestasis. The fraction of chenodeoxycholic acid synthesis excreted in urine ranged from 9 to 48%; 4--38% of chenodeoxycholic acid synthesis was sulfated. These data indicate that the major abnormalities in bile acid metabolism in patients with cholestasis secondary to primary biliary cirrhosis are formation of sulfated bile acids in greatly increased amounts, elevation of blood levels of primary bile acids, and a shift to renal excretion as a major mechanism for bile acid elimination. Chenodeoxycholic acid synthesis continues at its usual rate despite cholestasis. Whether these changes, including the formation of 7-monosulfated bile acids, occur in other forms of cholestasis and whether either the persistance of unchanged chenodeoxycholic acid synthesis or the formation of such novel conjugates has any pathophysiological significance remain to be investigated.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249880     DOI: 10.1007/bf01313580

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Hydrolysis of ketosteroid hydrogen sulfates by solvolysis procedures.

Authors:  S BURSTEIN; S LIEBERMAN
Journal:  J Biol Chem       Date:  1958-08       Impact factor: 5.157

2.  Primary bile acid kinetics in patients with primary biliary cirrhosis and in normal subjects.

Authors:  C N Williams; I A MacDonald; H Park-Dincsoy
Journal:  Clin Invest Med       Date:  1979       Impact factor: 0.825

3.  Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Authors:  G P van Berge Henegouwen; K H Brandt; H Eyssen; G Parmentier
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

4.  Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.

Authors:  R C Danzinger; A F Hofmann; J L Thistle; L J Schoenfield
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

5.  Asymptomatic primary biliary cirrhosis. Presentation, histology, and results with D-penicillamine.

Authors:  C R Fleming; J Ludwig; E R Dickson
Journal:  Mayo Clin Proc       Date:  1978-09       Impact factor: 7.616

6.  Effect of cholestyramine on bile acid kinetics in patients with portal cirrhosis of the liver. Evidence of a selective defect in the formation of cholic acid.

Authors:  B Angelin; K Einarsson; K Hellstrom
Journal:  Am J Dig Dis       Date:  1978-12

7.  Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease.

Authors:  T A Miettinen
Journal:  Gut       Date:  1972-09       Impact factor: 23.059

8.  Evidence for renal control of urinary excretion of bile acids and bile acid sulphates in the cholestatic syndrome.

Authors:  J A Summerfield; J Cullen; S Barnes; B H Billing
Journal:  Clin Sci Mol Med       Date:  1977-01

9.  Identification of the 3-sulfate isomer as the major product of enzymatic sulfation of chenodeoxycholate conjugates.

Authors:  R B Kirkpatrick; L Lack; P G Killenberg
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

10.  Bile acid sulfates. III. Synthesis of 7- and 12-monosulfates of bile acids and their conjugates using a sulfur trioxide-triethylamine complex.

Authors:  K Y Tserng; P D Klein
Journal:  Steroids       Date:  1979-02       Impact factor: 2.668

View more
  14 in total

Review 1.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

Authors:  Paul A Dawson; Melissa L Hubbert; Anuradha Rao
Journal:  Biochim Biophys Acta       Date:  2010-06-09

2.  Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice.

Authors:  Youcai Zhang; Curtis D Klaassen
Journal:  J Lipid Res       Date:  2010-07-29       Impact factor: 5.922

Review 3.  Molecular mechanisms of cholestasis.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Wien Med Wochenschr       Date:  2006-07

4.  Pharmacokinetic study of cyclosporin A (Sandimmun) in patients with primary biliary cirrhosis.

Authors:  S Robson; J Neuberger; H P Keller; E Abisch; W Neiderberger; B von Graffenried; R Williams
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

5.  MALDI imaging MS reveals candidate lipid markers of polycystic kidney disease.

Authors:  Hermelindis Ruh; Theresia Salonikios; Jens Fuchser; Matthias Schwartz; Carsten Sticht; Christina Hochheim; Bernhard Wirnitzer; Norbert Gretz; Carsten Hopf
Journal:  J Lipid Res       Date:  2013-07-12       Impact factor: 5.922

6.  Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration.

Authors:  A Lanzini; M G De Tavonatti; B Panarotto; S Scalia; A Mora; F Benini; O Baisini; F Lanzarotto
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

Review 7.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

8.  Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.

Authors:  C H Janes; E R Dickson; R Okazaki; S Bonde; A F McDonagh; B L Riggs
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 9.  Intestinal transport and metabolism of bile acids.

Authors:  Paul A Dawson; Saul J Karpen
Journal:  J Lipid Res       Date:  2014-09-10       Impact factor: 5.922

10.  Enzymatic determination of serum 12 alpha-hydroxy bile acid concentration with 12 alpha-hydroxysteroid dehydrogenase.

Authors:  N Tamasawa; M Yoneda; I Makino; K Takebe; S Ueda; H Misaki
Journal:  Gastroenterol Jpn       Date:  1988-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.